The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. That said, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where its enthusiasm might be excessive.
Two Stocks to Sell:
Sotera Health Company (SHC)
Consensus Price Target: $20.13 (29.5% implied return)
With a critical role in ensuring the safety of millions of patients worldwide, Sotera Health (NASDAQGS:SHC) provides sterilization services, lab testing, and advisory services to ensure medical devices, pharmaceuticals, and food products are safe for use.
Why Do We Think Twice About SHC?
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Modest revenue base of $1.19 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Free cash flow margin dropped by 8.4 percentage points over the last five years, implying the company became more capital intensive as competition picked up
At $15.54 per share, Sotera Health Company trades at 15.7x forward P/E. Dive into our free research report to see why there are better opportunities than SHC.
Hudson Technologies (HDSN)
Consensus Price Target: $8.50 (72.6% implied return)
Founded in 1991, Hudson Technologies (NASDAQ: HDSN) specializes in refrigerant services and solutions, providing refrigerant sales, reclamation, and recycling.
Why Are We Out on HDSN?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 4.7% annually over the last two years
- Diminishing returns on capital suggest its earlier profit pools are drying up
- Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution
Hudson Technologies’s stock price of $4.93 implies a valuation ratio of 0.8x trailing 12-month price-to-sales. Read our free research report to see why you should think twice about including HDSN in your portfolio.
One Stock to Buy:
Napco (NSSC)
Consensus Price Target: $50.33 (32.6% implied return)
Protecting everything from schools to government facilities since 1969, Napco Security Technologies (NASDAQ: NSSC) manufactures electronic security devices, access control systems, and communication services for intrusion and fire alarm systems.
Why Are We Backing NSSC?
- Annual revenue growth of 14.2% over the past five years was outstanding, reflecting market share gains this cycle
- Strong free cash flow margin of 19.8% enables it to reinvest or return capital consistently, and its improved cash conversion implies it’s becoming a less capital-intensive business
- Improving returns on capital reflect management’s ability to monetize investments
Napco is trading at $37.95 per share, or 24.4x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
